InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 284.90
-7.50 (-2.56%)
Aug 11, 2026, 5:24 PM IDT
InterCure Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 156 | 177 | 272 | 211 | 551 | 932 | |
Market Cap Growth | -42.72% | -34.89% | 28.77% | -61.66% | -40.95% | 111.63% |
Enterprise Value | 292 | 306 | 404 | 290 | 560 | 822 |
Last Close Price | 2.85 | 3.24 | 5.94 | 4.63 | 12.08 | 20.72 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 12.28 | 198.78 |
PS Ratio | 0.58 | 0.66 | 1.14 | 0.59 | 1.42 | 4.24 |
PB Ratio | 0.39 | 0.45 | 0.68 | 0.46 | 1.06 | 1.99 |
P/TBV Ratio | 0.88 | 1.00 | 1.58 | 0.90 | 2.54 | 5.19 |
P/FCF Ratio | 11.72 | 13.31 | - | - | 17.46 | 57.88 |
P/OCF Ratio | 9.25 | 10.51 | - | - | 10.74 | 30.94 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.08 | 1.13 | 1.69 | 0.82 | 1.44 | 3.74 |
EV/EBITDA Ratio | - | - | - | 21.85 | 10.78 | 21.96 |
EV/EBIT Ratio | - | - | - | 2761.28 | 13.91 | 27.37 |
EV/FCF Ratio | 21.97 | 23.01 | - | - | 17.76 | 51.06 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.46 | 0.46 | 0.53 | 0.43 | 0.49 | 0.23 |
Debt / EBITDA Ratio | - | - | - | 14.74 | 4.91 | 2.91 |
Debt / FCF Ratio | 13.77 | 13.77 | - | - | 8.09 | 6.76 |
Net Debt / Equity Ratio | 0.34 | 0.34 | 0.33 | 0.21 | 0.04 | -0.19 |
Net Debt / EBITDA Ratio | -2.46 | -2.46 | -1.70 | 7.11 | 0.43 | -2.34 |
Net Debt / FCF Ratio | 10.26 | 10.26 | -1.86 | -1.68 | 0.71 | -5.44 |
Asset Turnover | 0.37 | 0.37 | 0.31 | 0.41 | 0.47 | 0.43 |
Inventory Turnover | 2.01 | 2.01 | 1.74 | 2.01 | 2.14 | 2.88 |
Quick Ratio | 0.91 | 0.91 | 0.96 | 1.02 | 0.95 | 1.19 |
Current Ratio | 1.48 | 1.48 | 1.73 | 1.85 | 1.69 | 1.74 |
Return on Equity (ROE) | -9.26% | -9.26% | -17.03% | -12.98% | 8.83% | 1.92% |
Return on Assets (ROA) | -5.78% | -5.78% | -7.09% | 0.01% | 3.04% | 3.67% |
Return on Invested Capital (ROIC) | -12.62% | -12.65% | -16.25% | 0.02% | 8.67% | 3.65% |
Return on Capital Employed (ROCE) | -14.10% | -14.10% | -16.40% | 0.00% | 6.20% | 6.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -22.92% | -20.18% | -24.95% | -29.36% | 8.14% | 0.50% |
FCF Yield | 8.53% | 7.51% | -26.24% | -26.65% | 5.73% | 1.73% |
Buyback Yield / Dilution | -17.17% | -17.17% | -0.65% | -0.48% | -11.05% | -60.81% |